Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9344 |
3-Amino-2-oxazolidinone
|
Others; Endogenous Metabolite | Metabolism; Others |
3-Amino-2-oxazolidinone 是一种呋喃唑烷酮的代谢物 (metabolite),可用作检测呋喃唑烷酮残留的一个指标。 | |||
T7419 |
Sutezolid
PNU-100480,U-100480,PF-02341272 |
Antibacterial; Antibiotic | Microbiology/Virology |
Sutezolid (U-100480) 是一种具有口服活性恶唑烷酮抗菌剂,通过抑制细菌蛋白质合成发挥作用。它有抗分枝杆菌活性,可研究耐药结核病。 | |||
T11123 |
DuP 105
|
Antibacterial; Antibiotic | Microbiology/Virology |
DuP 105是可口服的oxazolidinone类化合物,这是一种新型合成的抗菌化合物,对革兰氏阳性细菌具有有效性。 | |||
T1747 |
Tedizolid
TR 700,特地唑胺,DA-7157,泰地唑利,Torezolid |
MAO; Antibacterial; Antibiotic | Metabolism; Microbiology/Virology; Neuroscience |
Tedizolid (DA-7157)是一种新型恶唑烷酮类抗生素,可与核糖体50S 亚基的23S 核糖体 RNA 结合抑制细菌的蛋白质合成。 | |||
T16718 |
Radezolid
RX-1741,雷得唑来 |
Antibacterial; Antibiotic | Microbiology/Virology |
Radezolid (RX-1741) 是一种噁唑烷酮类抗生素。它对衣原体,军团菌葡萄球菌,和Linezolid 耐药菌株有活性。 | |||
T4020 |
Cadazolid
ACT-179811,卡达唑利德 |
Antibacterial; Antibiotic | Microbiology/Virology |
Cadazolid (ACT-179811) 是一种新型恶唑烷酮类抗生素,对Clostridium difficile 有活性。 | |||
T6998 |
Tedizolid Phosphate
TR-701FA,Torezolid phosphate,磷酸特地唑胺 |
Antibacterial; Antibiotic | Microbiology/Virology |
Tedizolid Phosphate (TR-701FA) 是 MAO-A 和 MAO-B 抑制剂,具有抗革兰氏阳性菌的活性。 | |||
T12512 |
PNU288034
|
Antifungal | Microbiology/Virology |
PNU288034 是一种有效的恶唑烷酮类抗生素,具有抗菌活性,可用于预防和治疗革兰氏菌感染。 | |||
T15237 |
Eperezolid
PNU-100592 |
Antibacterial; Antibiotic | Microbiology/Virology |
Eperezolid (PNU-100592) 是一种在体外表现出良好抑制活性的恶唑烷酮类抗生素。 | |||
T0391 |
Linezolid
PNU-100766,雷奈佐利 |
MAO; Antibacterial; Antibiotic | Metabolism; Microbiology/Virology; Neuroscience |
Linezolid (PNU-100766) 是恶唑烷酮类合成抗生素,抑制细菌蛋白质合成的起始阶段,具有抗感染作用。 | |||
T0383 |
Fenspiride hydrochloride
Fenspiride HCl,Pneumorel,Fluiden,Decaspiride,盐酸芬司必利 |
Adrenergic Receptor; PDE; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Metabolism; Neuroscience |
Fenspiride hydrochloride (Decaspiride) 是一种口服活性的非甾体抗炎剂,是 H1-组胺受体的拮抗剂,可用于呼吸系统疾病的研究。 | |||
T1184 |
Rivaroxaban
BAY 59-7939,利伐沙班 |
Factor Xa; Thrombin | Metabolism; Proteases/Proteasome |
Rivaroxaban (BAY 59-7939) 是高效选择性的凝血因子 Xa (FXa) 直接抑制剂,IC50=0.7 nM,Ki 为 0.4 nM。 | |||
T4165 |
Delpazolid
LCB01-0371 |
Antibacterial; Antibiotic | Microbiology/Virology |
Delpazolid (LCB01-0371) 是一种恶唑烷酮类新型抗生素,能抑制MSSA 和MRSA 的生长,对它们的MIC90值都为 2 μg/mL。 | |||
T13455 |
(S)-Tedizolid
(S)-TR 700,(S)-特地唑胺,(S)-DA 7157 |
Others | Others |
(S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. | |||
T34115 |
Posizolid
AZD 2563,AZD-5847,AZD-2563, Posizolid,AZD5847,AZD 5847,AZD2563 |
||
Posizolid(AZD-5847,AZD-2563) is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. | |||
T39230 |
Contezolid acefosamil
MRX-4,Contezolid acefosamil |
||
Contezolid acefosamil (MRX-4), an orally active prodrug, is metabolized into Contezolid (MRX-I), an oxazolidinone derivative with potent in vitro efficacy against multidrug-resistant Gram-positive bacteria, including MRSA. | |||
T40998 |
S-6123
|
||
S-6123 is a highly effective antimicrobial compound classified under the oxazolidinone series, and it acts by selectively inhibiting ribosomal protein synthesis while not affecting DNA or RNA synthesis. | |||
T37841 |
PNU 142300
|
||
PNU 142300 is an inactive metabolite of the oxazolidinone antibiotic linezolid . | |||
T23451 |
Tedizolid HCl (856866-72-3 free base)
Tedizolid HCl |
Others | Others |
Tedizolid HCl is a reversible, novel oxazolidinone antibiotic (IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM). It is the first oxazolidinone to be approved since linezolid in 2000. Tedizolid phosphate is the second commercially availabl | |||
T1747L |
Tedizolid phosphate disodium salt
Torezolid phosphate sodium salt,DA 7218,TR-701,TR 701 |
||
Tedizolid phosphate is a novel antibacterial prodrug. Tedizolid phosphate is a next-generation oxazolidinone with activity against both methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp. It also has effective activity a | |||
T37350 |
TBI-223
|
||
TBI-223 is an orally bioavailable oxazolidinone antibiotic with antimicrobial properties. It exhibits potent activity against Mycobacterium tuberculosis (Mtb)[1][2]. | |||
T23947 |
DA-7867
UNII-491MT9GU8K,DA 7867,DA7867 |
||
DA-7867 is a novel oxazolidinone. DA-7867 had the lowest MIC for 90% of the aerobic gram-positive bacterial strains tested (≤0.25 μg/ml) and it was more potent than linezolid. DA-7867 was the most active drug with a MIC(90) of 0.125 μg/ml. | |||
T36441 |
Contezolid acefosamil sodium
|
||
Contezolid acefosamil sodium (MRX-4) is a novel orally active oxazolidinone antibiotic under investigation for the treatment of complicated skin and soft tissue infections (cSSTI) caused by drug-resistant Gram-positive bacteria. It possesses strong efficacy against these pathogens while significantly minimizing the risks of myelosuppression and monoamine oxidase inhibition (MAOI) [1][2]. | |||
T41085 |
UK122
UK122 |
||
UK122 is a highly effective and specific inhibitor of urokinase-type plasminogen activator (uPA) with an IC50 value of 0.2 μM. It displays negligible to minimal inhibition towards tissue-type plasminogen activator (tPA), plasmin, thrombin, and trypsin (all IC50 >100 μM). Functioning as a 4-oxazolidinone analogue, UK122 is an anticancer agent that effectively inhibits cancer cell migration and invasion. |